Durata Therapeutics Inc (DRTX) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
200 SOUTH WACKER DRIVE CHICAGO, IL 60606 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 9/30/2014 Q3 | 6/30/2014 Q2 | 3/31/2014 Q1 | 12/31/2013 Q4 | 9/30/2013 Q3 | 6/30/2013 Q2 | 3/31/2013 Q1 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 34,711 | 41,541 | 59,733 | 66,593 | 83,479 | 46,728 | |||
| Cash and cash equivalents | 20,900 | 20,669 | 36,853 | 44,485 | 61,384 | 32,642 | |||
| Short-term investments | 13,811 | 20,872 | 22,880 | 22,108 | 22,095 | 14,087 | |||
| Receivables | |||||||||
| Inventory, net of allowances, customer advances and progress billings | ✕ | ✕ | ✕ | ✕ | |||||
| Inventory | |||||||||
| Prepaid expense | 643 | ||||||||
| Prepaid expense and other current assets | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 3,996 | ||
| Income taxes receivable | ✕ | ✕ | ✕ | 1,971 | |||||
| Deferred tax assets | 35 | ||||||||
| Other undisclosed current assets | 6,875 | 3,955 | 718 | 3,039 | 1,857 | ||||
| Total current assets: | 41,586 | 45,496 | 63,100 | 69,632 | 85,335 | 50,724 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 766 | 831 | 897 | 962 | 1,009 | 1,047 | |||
| Intangible assets, net (including goodwill) | 20,976 | 21,103 | 21,103 | 21,103 | 21,103 | 21,103 | |||
| Goodwill | 5,811 | 5,811 | 5,811 | 5,811 | 5,811 | 5,811 | |||
| Intangible assets, net (excluding goodwill) | 15,165 | 15,292 | 15,292 | 15,292 | 15,292 | 15,292 | |||
| Restricted cash and investments | 2,247 | 997 | 1,147 | 1,146 | 1,145 | 1,143 | |||
| Deferred costs | 419 | ||||||||
| Other noncurrent assets | 3,871 | 3,904 | 3,816 | 512 | 576 | ||||
| Prepaid expense and other noncurrent assets | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 865 | ||
| Other undisclosed noncurrent assets | 9,997 | 10,081 | 9,662 | 11,487 | 11,235 | 11,235 | |||
| Total noncurrent assets: | 37,857 | 36,916 | 37,044 | 35,210 | 35,068 | 35,394 | |||
| TOTAL ASSETS: | 79,443 | 82,412 | 100,144 | 104,842 | 120,404 | 86,118 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 10,060 | 12,689 | 16,279 | 8,999 | 13,825 | 15,516 | |||
| Taxes payable | 573 | 1,609 | 32 | 453 | |||||
| Employee-related liabilities | 2,279 | ||||||||
| Accounts payable | 3,725 | 3,204 | 5,275 | 2,729 | 5,228 | 11,124 | |||
| Accrued liabilities | 6,335 | 8,912 | 7,116 | 6,238 | 8,597 | 3,939 | |||
| Debt | 1,000 | 313 | 2,841 | 1,205 | |||||
| Other undisclosed current liabilities | (2,279) | ||||||||
| Total current liabilities: | 11,060 | 13,002 | 14,000 | 11,839 | 15,029 | 15,516 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 39,000 | 24,687 | 25,000 | 15,873 | 17,352 | 18,406 | |||
| Long-term debt, excluding current maturities | 39,000 | 24,687 | 25,000 | 15,873 | 17,352 | 18,406 | |||
| Liabilities, other than long-term debt | 1,655 | 1,666 | 1,676 | 1,840 | 1,412 | 1,412 | |||
| Accounts payable and accrued liabilities | |||||||||
| Accrued income taxes | ✕ | 1,377 | 1,377 | 1,377 | 1,358 | 1,412 | 1,412 | ||
| Other liabilities | 278 | 289 | 299 | 482 | |||||
| Other undisclosed noncurrent liabilities | 25,000 | 23,587 | 20,889 | 21,865 | 21,917 | 21,637 | |||
| Total noncurrent liabilities: | 65,655 | 49,940 | 47,565 | 39,578 | 40,681 | 41,454 | |||
| Total liabilities: | 76,715 | 62,942 | 61,565 | 51,417 | 55,711 | 56,970 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 2,728 | 19,470 | 38,579 | 53,425 | 64,693 | 29,147 | |||
| Common stock | 268 | 266 | 266 | 266 | 266 | 184 | |||
| Additional paid in capital | 209,772 | 208,602 | 207,754 | 206,960 | 206,330 | 152,031 | |||
| Accumulated deficit | |||||||||
| Other undisclosed equity, attributable to parent | (207,312) | (189,398) | (169,441) | (153,802) | (141,903) | (123,068) | |||
| Total equity: | 2,728 | 19,470 | 38,579 | 53,425 | 64,693 | 29,147 | |||
| TOTAL LIABILITIES AND EQUITY: | 79,443 | 82,412 | 100,144 | 104,842 | 120,404 | 86,118 | |||
Income Statement (P&L) ($ in thousands)Annual | Quarterly
| 9/30/2014 Q3 | 6/30/2014 Q2 | 3/31/2014 Q1 | 12/31/2013 Q4 | 9/30/2013 Q3 | 6/30/2013 Q2 | 3/31/2013 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues (Revenue, Net) | ||||||||
| Gross profit: | ||||||||
| Operating expenses | (18,790) | (19,010) | (12,613) | (11,017) | (17,982) | (15,486) | ||
| Other operating income (expense), net | (911) | (882) | (2,530) | (625) | (643) | 93 | ||
| Other undisclosed operating income | 911 | 948 | 2,596 | 625 | 643 | 30,819 | ||
| Operating income (loss): | (18,790) | (18,944) | (12,547) | (11,017) | (17,982) | 15,426 | ||
| Nonoperating income (expense) (Other Nonoperating Income (Expense)) | 115 | |||||||
| Interest and debt expense | (108) | |||||||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | (1,727) | |||||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (18,675) | (18,944) | (14,274) | (11,017) | (17,982) | 15,318 | ||
| Other undisclosed income (loss) from continuing operations before income taxes | (1,026) | (882) | (803) | (625) | (643) | 201 | ||
| Income (loss) from continuing operations before income taxes: | (19,701) | (19,826) | (15,076) | (11,642) | (18,626) | 15,519 | ||
| Income tax expense (benefit) | 1,787 | (131) | (563) | (257) | (210) | (248) | ||
| Income (loss) from continuing operations: | (17,914) | (19,957) | (15,640) | (11,899) | (18,835) | 15,271 | ||
| Income (loss) before gain (loss) on sale of properties: | (17,914) | (19,957) | (15,640) | (11,899) | (18,835) | 15,271 | ||
| Other undisclosed net loss | (31,039) | |||||||
| Net loss available to common stockholders, diluted: | (17,914) | (19,957) | (15,640) | (11,899) | (18,835) | (15,767) | ||
Comprehensive Income ($ in thousands)Annual | Quarterly
| 9/30/2014 Q3 | 6/30/2014 Q2 | 3/31/2014 Q1 | 12/31/2013 Q4 | 9/30/2013 Q3 | 6/30/2013 Q2 | 3/31/2013 Q1 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (17,914) | (19,957) | (15,640) | (11,899) | (18,835) | (15,767) | ||
| Comprehensive loss, net of tax, attributable to parent: | (17,914) | (19,957) | (15,640) | (11,899) | (18,835) | (15,767) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.